Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
We are delighted that the authors of the letter1 see merit in what we have done, and the previous imaging studies in age-related macular degeneration (AMD) that they cite served as inspiration for our intervention. We agree wholeheartedly with the need for better imaging, especially swept-source optical coherence tomography (SS-OCT) imaging of the choroid both before and after the ophthalmic artery (OA) intervention.2 Our …
Contributors All authors contributed equally.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests PNL: consultant for OcuDyne, Phenox, Medtronic; institutional grant or contract from Philips. TZ: consultant for OcuDyne. MC: consultant for OcuDyne.
Provenance and peer review Commissioned; externally peer reviewed.